1.
Cefoperazone Sodium and
头孢哌酮钠舒巴坦钠
2.
Analysis of the Allergic Shock Induced by Cefoperazone Sodium/Sulbactam Sodium in 33 Cases
33例头孢哌酮/舒巴坦过敏性休克分析
3.
The analysis of related substances in Sulbactam Sodium by HPLC
舒巴坦钠相关物质高效液相色谱分析
4.
The stability of cefoperazone sodium and sulbactam sodium for injection was studied.
考察了注射用头孢哌酮钠舒巴坦钠的稳定性。
5.
The clinical application of Sulperazon during perioperation of renal transplantation
头孢哌酮/舒巴坦在肾移植围手术期临床应用
6.
Evidence-Based Analysis of Thrombocytopenia Caused by Cefoperazone/Sulbactam
头孢哌酮/舒巴坦引起血小板减少症的循证分析
7.
Determination of cefotaxime sodium/sulbactam sodium for injection by HPLC
HPLC法测定注射用头孢噻肟钠/舒巴坦钠的含量
8.
Study on Quality Standard for Piperacillin Sodium and Sulbactam Sodium for Injection
哌拉西林钠舒巴坦钠粉针剂的质量标准研究
9.
Determination of 2-Ethylhexanoic Acid in Sulbactam Sodium by GC
气相色谱法检测舒巴坦钠中的2-乙基己酸
10.
A case report of infusion reaction caused by cefoperazone sodium and sulbactam sodium
静脉滴注头孢哌酮钠舒巴坦钠致输液反应1例
11.
Study on Pharmacokinetics of Cefotaxime Sodium-Sulbactam Sodium Injection;
注射用头孢噻肟钠舒巴坦钠人体内药代动力学研究
12.
Detection of β-lactamases in Bacteria from Swine and Avian and Primary Study for Their Inhibitor, Sulbactam;
猪鸡常见致病菌β-内酰胺酶的检测及其抑制剂舒巴坦的初步研究
13.
In Vivo and in Vitro Antibacterial Activities of Mezlocillin/Sulbactam and Evaluation of Its Clinical Efficacy Against Infectious Disease;
美洛西林/舒巴坦体内外杀菌活性及其对感染性疾病临床疗效评价
14.
Comparison of Activities of Three Sulbactam Complex Against Imipenem Resistant Acinetobacter Baumannii Infections:A Meta Analysis
耐亚胺培南鲍曼不动杆菌对3种舒巴坦复合剂耐药性的meta分析
15.
Improvement for determination of related substances concentration in ampicillin sodium/sulbactam sodium for injection
注射用氨苄西林钠舒巴坦钠中有关物质HPLC检测方法的改进
16.
Clinical Efficacy of Cefoperazone/sulbactam for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
头孢哌酮/舒巴坦治疗重度慢性阻塞性肺疾病急性加重期临床分析
17.
Analysis of 184 Adverse Drug Reaction/Event Reports of Cefoperazone Sodium and Sulbactam Sodium for Injection
184例注射用头孢哌酮钠舒巴坦钠不良反应/事件分析
18.
Phase Ⅰ clinical toleratnce study of cefuroxime/sulbactam
注射用头孢呋辛钠/舒巴坦钠Ⅰ期临床耐受性试验研究